Staying on Mounjaro long-term: what a maintenance dose for life actually means

You've reached a stable dose, now what happens if you stay there?

Picture this: you've been on Mounjaro for several months. The nausea from earlier doses has settled, your appetite is noticeably lower, and your weight has been stable for eight or ten weeks. Your prescriber hasn't suggested moving up. So the question that arrives, quietly, is whether this is where you stay, not just for now, but possibly for years.

That is genuinely what 'maintenance dose for life' means in practice. Not a single defined milligram written into a protocol, but a stable, well-tolerated dose that your prescriber is comfortable leaving unchanged because it is doing the job. The Mounjaro overview on our site explains how the titration schedule works in full, but the short version is this: titration is a process of finding your personal ceiling, not a countdown to a mandatory endpoint.

The UK licence for tirzepatide specifies weight management alongside a reduced-calorie diet and increased physical activity. It does not name a maximum duration. That is deliberate, obesity is a chronic condition, and the licence reflects that. The BNF's tirzepatide entry, the professional reference used by UK prescribers, describes treatment without a time cap.

One practical habit worth building: once a month, weigh yourself at the same time of day, on the same scale, after the same morning routine. A simple note on your phone takes thirty seconds and gives your prescriber something concrete to work with at each review.

What the trial data says about stopping versus continuing

The clearest evidence for long-term use comes from the SURMOUNT programme. In SURMOUNT-1, participants who continued tirzepatide at their maintenance dose sustained the weight reductions seen during the first phase of the trial. Participants who switched to placebo regained a substantial portion of lost weight within months. The pattern is consistent across GLP-1 and dual-agonist trials: the medicine works while you take it.

This is not a criticism of the treatment, it is how chronic-condition medicines behave. Antihypertensives lower blood pressure while you take them; stopping raises it again. The same logic applies here. SURMOUNT-1, published in the New England Journal of Medicine, reported average weight reductions around 20–21% at 15 mg over 72 weeks. Those numbers held for people who stayed on treatment. They did not hold for people who came off it.

This evidence is why 'maintenance dose for life' is a question many people are right to ask, and why the answer is nuanced rather than automatic. Some people do pause or stop, for clinical reasons, personal preference, or cost. That is a legitimate choice. But it should be a deliberate one, made with accurate information about what is likely to follow.

If you are weighing the financial side of long-term treatment, our Mounjaro pricing page sets out what private treatment costs and what is included in a single transparent price.

Which dose counts as 'maintenance' and can it be lower than 15 mg?

There is a common assumption that maintenance means the highest licensed dose. It does not. Your maintenance dose is the highest strength you tolerate well, and for some people that is 5 mg, for others 10 mg, for others the full 15 mg. The licensed titration schedule runs from 2.5 mg upward in roughly four-week steps, but the prescription decision rests with your prescriber, not with the packaging.

Some people find good results at a mid-range dose and see no clinical reason to push higher. Others find that a lower dose they tolerated well early on becomes less effective over time and move up. The dose conversion chart on our site maps the full schedule if you want to see where you sit in the sequence.

What the prescriber is looking for is a dose that is effective (meaning measurable continued benefit) and tolerable, meaning side effects are manageable. If 10 mg is doing that job without the GI disruption that 12.5 mg caused, 10 mg may well be the right long-term dose for you. Pages like is 7.5 mg Mounjaro a maintenance dose and is 5 mg Mounjaro a maintenance dose address this question at specific dose levels if you want more detail.

One thing worth knowing: the 2.5 mg dose is a starter strength, designed to ease your system into the treatment rather than to sustain results. Staying at 2.5 mg long-term is almost never the clinical intent, but even that is a conversation for a prescriber, not a rule to follow without context.

How ongoing clinical review shapes long-term treatment at nume

Long-term Mounjaro use is not a prescription you renew automatically. At nume, a real clinician (a GPhC-registered Independent Prescriber) reads your answers and reassesses your suitability before every repeat order. No algorithm makes that call. That regular review is what allows safe, ongoing treatment: it catches changes in health status, flags interactions, and checks that the medicine is still doing what it should.

The NHS England guidance on weight-management injections sets out the expectation that patients are monitored throughout treatment, not just at the start. Private prescribing follows the same clinical principles, and should. If a service is sending repeat supplies without any review, that is worth questioning.

If you are considering Mounjaro for the long term and want to understand whether it suits your situation, starting a free consultation with our prescribers is the right next step. There is no commitment attached, and the assessment is the same day.